BioXcel Therapeutics, Inc. (BTAI)
CIK 1720893 · all EDGAR filings →
Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.
Shares outstanding over time
Latest: 31.3M shares as of Aug 11, 2026 (10-Q). Share count fell from 42.7M to 5.5M between Oct 31, 2024 and Mar 26, 2025, a pattern consistent with a reverse split (roughly 1-for-8); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.
Cash runway
Going-concern warning
auditor flagged substantial doubt
The company itself flagged going-concern doubt in a filing.
Full breakdown: cash runway tool · source filing →
Warrants
| Tranche | Warrants | Exercise price | Term | Notes |
|---|---|---|---|---|
| March2026 Accompanying Warrants | 4.5M | $1.61 | — | — |
| Option Warrants March2025 | 4.0M | $3.5 | — | — |
| March2025 Accompanying Warrants | 4.0M | $4.2 | — | — |
| March2025 Prefunded Warrants | 3.8M | $0.001 | — | — |
| March2026 Pre Funded Warrants | 2.0M | $0.001 | — | — |
| Warrants2025 Accompanying Warrants | 1.7M | not tagged | — | — |
| Accompanying Warrants March2025 | 1.7M | $4.2 | — | — |
| November Warrants2024 Repriced Accompanying Warrants | 846,000 | $1.614 | 5y | — |
| November2024 Accompanying Warrants | 846,000 | $1.614 | — | — |
| November2024 Prefunded Accompanying Warrants | 563,000 | $0.016 | — | — |
| Warrants2024 Accompanying Warrants Strike Price Amended | 539,000 | $1.614 | 5y | — |
| Warrants2024 Accompanying Warrants | 539,000 | $51.2 | — | — |
Tranches exactly as the company dimensioned them in its 10-Q filed Aug 13, 2026 →. Groupings can overlap (a “Series E and F” row is not additive with a “Series E” row), so do not sum this column. A tranche the filer did not tag is absent here, not absent from the cap table. DOWN-ROUND = the filer tagged price-protection accounting scoped to that tranche.
Warrants outstanding: 7.9M underlying shares, as reported Jun 30, 2026 (10-Q).
Down-round (price protection) accounting has been tagged in this filer’s XBRL: some instrument carries repricing protection. Which tranche requires reading the exhibits.
Rough fully diluted estimate: 39.2M = 31.3M O/S + 7.9M warrant shares. An estimate, not a filing figure: it ignores converts, options and RSUs, and the two inputs carry different as-of dates.
Convertible notes
No convertible-note facts tagged in the 10-Q filed Aug 13, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.
Fully diluted build-up
Shares outstanding plus every potential-share instrument the filer tagged in XBRL, each at its own as-of date. An estimate assembled from filed figures, not a filing figure itself.
| Shares outstanding | 31.3M | Aug 11, 2026 |
| + March2026 Accompanying Warrants (if exercised) | 4.5M | Jun 30, 2026 |
| + Option Warrants March2025 (if exercised) | 4.0M | Mar 3, 2025 |
| + March2025 Accompanying Warrants (if exercised) | 4.0M | Mar 3, 2025 |
| + March2025 Prefunded Warrants (if exercised) | 3.8M | Mar 3, 2025 |
| + March2026 Pre Funded Warrants (if exercised) | 2.0M | Mar 10, 2026 |
| + Warrants2025 Accompanying Warrants (if exercised) | 1.7M | Jun 30, 2026 |
| + Accompanying Warrants March2025 (if exercised) | 1.7M | Jun 30, 2026 |
| + November Warrants2024 Repriced Accompanying Warrants (if exercised) | 846,000 | Jun 30, 2026 |
| + November2024 Accompanying Warrants (if exercised) | 846,000 | Jun 30, 2026 |
| + November2024 Prefunded Accompanying Warrants (if exercised) | 563,000 | Nov 22, 2024 |
| + Warrants2024 Accompanying Warrants Strike Price Amended (if exercised) | 539,000 | Jun 30, 2026 |
| + Warrants2024 Accompanying Warrants (if exercised) | 539,000 | Mar 10, 2026 |
| Fully diluted estimate | 56.4M | +80.1% vs O/S |
Still excluded, because the filer does not tag them in countable form: employee options and RSUs, any instrument living only in exhibit prose, and instruments above missing a share count. Inputs carry different as-of dates, shown per row. Each figure traces to the tranche and note tables above and their cited filings.
Registrations and offerings
Last 12 months: 3 executed · 0 registered.
Full history and shelf status: offering checker · S-3 shelf checker
Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.
Keep going: float checker · offering calendar · short-squeeze screener · full BTAI workspace